[Corticosteroid and anabolic hormone therapy of patients with arthropathic psoriasis and erythroderma].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D003873:Dermatitis, Exfoliative / Q000188:drug therapy*; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use*; D008875:Middle Aged; D011189:Potassium Chloride / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D014221:Triamcinolone / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D045930:Anabolic Agents; D006634:Histamine H1 Antagonists; D014815:Vitamins; D014221:Triamcinolone; D011189:Potassium Chloride; D003907:Dexamethasone; D011239:Prednisolone; D008696:Methandrostenolone
Lechenie kortikosteroidnymi i anabolicheskimi gormonami bol'nykh artropaticheskim psoriazom i eritrodermieĭ.